5Franceschi S, Herrero R, Clifford GM, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide[ J].Int J Cancer,2006,119: 2677 -2684. 被引量：1
6Smith JS, Amy M, Rashida K, et al. Age-specific revalence of infection with human pap illomavirus in females:a global review[J].J Adolese Health ,2008,43:23-25. 被引量：1
7Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide:a meta-analysis[J]. Br J Cancer,2003,88:63-73. 被引量：1
4Munoz N, Bosch FX, Sanjose S, et al. Epidemiologic clas-sification of human papillomavirus types associated withcervical cancer [J].N Engl J Med, 2003, 348 (6): 518-527. 被引量：1
5Walboomers JM, JacobsMV, ManosMM, et al. Human papillomavirus is a necessary cause of invasive cervical cancerworldwide [J].J Patho, 1999, 189: 12-19. 被引量：1
6Ding DC, H.C, Hsu, et al. Type-specific distribution of HPV along the full spectrum of cervical carcinogenesis in Taiwan: An indication of viral oncogenic potential [J ]. Eur J Obstet Gynecol Reprod Biol, 2008, 140 (2): 245-51. 被引量：1
7Clifford GM, Smith JS, PlummerM, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis[J]. Br J Cancer, 2003, 88: 63-73. 被引量：1
8Lo KW, Wong YF, Chan MK, et al. Prevalence of human papillomavirus in cervical cancer: amulticenter study in China [J]. Int J Cancer, 2002, 100: 327-331. 被引量：1
9Huang S, Afonina I, Miller BA, et al. Huamn papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinesewomen[J]. Int J Cancer, 1997, 73: 775-776. 被引量：1
10Bosch FX, Lorincz A, Munoz N, Meijer C J, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol, 2002, 55: 244-265. 被引量：1
1Schiffman M,Castle PE. The promise of global cervical-cancer prevention[J].New England Journal of Medicine,2005,(20):2101-2104.doi:10.1056/NEJMp058171. 被引量：1
2Katz IT,Wright AA. Preventing cervical cancer in the developing world[J].New England Journal of Medicine,2006,(11):1110.doi:10.1056/NEJMp068031. 被引量：1
3Cohen J. Public health.HPV's peculiarities,from infection to disease[J].Science,2005,(5722):619.doi:10.1126/science.308.5722.619. 被引量：1
4Aruhuri B,Tarivonda L,Tenet V. Prevalence of Cervical Human Papillomavirus (HPV) Infection in Vanuatu[J].Cancer Prev Res (Phila),2012,(05):746-753.doi:10.1158/1940-6207.CAPR-11-0515. 被引量：1
5Brotherton JM,Mullins RM. Will vaccinated women attend cervical screening? A population based survey of human papillomavirus vaccination and cervical screening among young women in Victoria,Australia[J].Cancer Epidemiol,2012,(03):298-302.doi:10.1016/j.canep.2011.11.005. 被引量：1
6Burger EA,Ortendahl JD,Sy S. Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway[J].British Journal of Cancer,2012,(09):1571-1578.doi:10.1016/j.joca.2009.02.013. 被引量：1
7Parvez R,Hedau S,Bhattacharya D. High-risk HPV infection among the tribal and non-tribal women of the Andaman and Nicobar Islands,India[J].Public Health,2012,(01):67-69.doi:10.1016/j.puhe.2011.09.018. 被引量：1
8Shi JF,Canfell K,Lew JB. The burden of cervical cancer in China:synthesis of the evidence[J].International Journal of Cancer,2012,(03):641-652.doi:10.1253/circj.CJ-09-0861. 被引量：1
9Wu D,Cai L,Huang M. Prevalence of genital human papillomavirus infection and genotypes among women from Fujian province,PR China[J].European Journal of Obstetrics & Gynecology and Reproductive Biology,2010,(01):86-90. 被引量：1
